A Multicenter Clinical Study of Ultrasound Multimodal Imaging in the Evaluation of Heart Transplantation
Launched by XIE MINGXING · Jul 13, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how ultrasound imaging can help doctors better understand the heart before and after a heart transplant. The goal is to evaluate how well the heart's upper and lower chambers are working, as well as to find non-invasive ways to identify problems like heart tissue scarring and to detect early signs of rejection or other complications in heart transplant patients.
To participate in this study, you need to be a healthy volunteer between the ages of 20 and 100. Unfortunately, if you have conditions like high blood pressure, diabetes, kidney failure, or other significant health issues, you won't be eligible. If you join the study, you can expect to undergo various ultrasound tests that are safe and painless to help gather important information about heart health in transplant patients. This research is significant as it aims to improve care and outcomes for those undergoing heart transplants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy volunteers
- Exclusion Criteria:
- • had history of hypertension, diabetes mellitus, renal failure or other organic diseases based on physical examinations, biochemical tests, electrocardiogram, echocardiography
About Xie Mingxing
Xie Mingxing is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing cutting-edge therapies and treatments, the organization collaborates with leading healthcare professionals and institutions to conduct rigorous clinical trials. Xie Mingxing prioritizes patient safety and ethical research practices, ensuring that all trials adhere to the highest standards of quality and regulatory compliance. Through its strategic approach and commitment to scientific excellence, Xie Mingxing aims to contribute significantly to the improvement of healthcare outcomes and the development of new medical solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Li Zhang, PhD
Principal Investigator
Department of Ultrasound, Union Hospital, Wuhan, China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials